Hanesbrands stock jumps toward a 5-month high after WSJ report of activist investor pushing for change
Shares of Hanesbrands Inc. (HBI) jumped 5.6% toward a five-month high in premarket trading Tuesday, after the The Wall Street Journal reported that activist investor Barington Capital is pushing the underwear company to make moves to reverse the weakness in the stock, and to make changes to its board of directors. Barington, which the WSJ report said has built up an undetermined stake in Hanesbrands, has told the company that it needs to immediately focus on cash generation and debt reduction, and said management's ineffective response to market challenges has led to rapidly deteriorating results. The stock has tumbled in early February, after the company reported disappointing results, warned of a surprise loss and eliminated its dividend. Hanesebrands' stock has dropped 18.1% year to date through Monday, while the S&P 500 has rallied 17.7%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-08-23 0741ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?